Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1514
Peer-review started: June 20, 2023
First decision: July 7, 2023
Revised: July 19, 2023
Accepted: August 15, 2023
Article in press: August 15, 2023
Published online: October 15, 2023
Processing time: 111 Days and 3.9 Hours
This study was founded on the understanding of the crucial role of insulin resistance (IR) in the development of type 2 diabetes mellitus (T2DM). A lack of insulin sensitivity in the body leads to increased insulin secretion by the pancreas, triggering hyperinsulinemia, and affecting the efficiency of glucose intake, ultimately leading to metabolic disorders.
Given that these metabolic disorders underlie several other conditions such as hypertension, dyslipidemia, coronary heart diseases, and obesity, finding effective ways to improve IR is a critical part of treating T2DM and preventing related diseases. The motivation was to evaluate risk factors for IR and study the effects of vitamin D supplementation on glucose and lipid metabolism in patients with T2DM and IR.
To identify independent risk factors for IR in T2DM patients and investigate the effects of vitamin D supplementation on their glucose and lipid metabolism.
The study carried out a comprehensive evaluation of risk factors for IR in T2DM patients, including parameters like BMI, TG, HDL-C, 25(OH)D3, 2hPG, and HbA1c. Furthermore, it explored the impact of vitamin D supplementation on glucose and lipid metabolism in T2DM patients with IR.
The study found that BMI, TG, HDL-C, 25(OH)D3, 2hPG, and HbA1c were independent risk factors for IR. After vitamin D supplementation, the test group showed notable decreases in 2hPG, FBG, HbA1c and a notable increase in 25-hydroxyvitamin D (25(OH)D3), as well as lower TG and TC levels but higher HDL-C level than the control group.
Patients with IR exhibit significant abnormalities in glucose and lipid metabolism parameters compared to the non-insulin-resistant group. The study concluded that 25(OH)D3 is an independent risk factor influencing IR and supplementation of vitamin D has been shown to improve glucose and lipid metabolism in patients with IR and T2DM.
While promising, the study has some limitations including the need for long-term patient prognosis and the possibility of bias due to it being a single-center study with limited participants. Further clinical experiments are needed to verify and improve the research conclusions, especially to assess the long-term efficacy of vitamin D supplementation.